Alavar, Ruby Jane .
HRN: 26-04-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2025
CEFUROXIME 1.5GM (VIAL)
01/23/2025
01/24/2025
IV
1.5 G
Q8 X 3 Doses
Sp Repeat LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes